Detecting ovarian cancer

Israel’s Nevia Bio (previously Gina Life) specializes in women’s health, using its innovative machine-learning platform to detect diseases while they are still curable. Nevia is initially targeting ovarian cancer, which has a less than 20% survival rate at stage 3 and currently has no early detection.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *